Shares Surge On News From U.S. Medicare And Medicaid Services

2024-08-19 03:28:33

(MENAFN- Yolo Wire) News that this company’s first-of-a-kind medical solution has received coding and pricing determinations from CMS is sending shares higher in Monday morning trade.

%ThermaBright Inc. (TSXV: $THRM) (OTC: $TBRIF) is a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies. The company announced in a press release today that its Venowave VW5 has received the permanent Healthcare Common Procedure Coding System (HCPCS) code from the U.S. Department of health & Human Services Centers for Medicare and Medicaid Services (CMS) on August 16, 2024.

Rob Fia, CEO of Therma Bright, said,“We’re pleased that the Centers for Medicare and Medicaid has approved our permanent code request, as well as the reimbursement pricing and the new HCPCS Level II designation for our Venowave VW5 device.”

The CDC estimates that over 900,000 U.S. citizens suffer from deep vein thrombosis (DVT), and other research projects this disease will reach USD 1.5 billion by 2032 globally.

Canadian shares were moving higher in heavy trade.

MENAFN19082024007606016353ID1108577294

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.